Dr. Anish S Majumdar who serves as the Chief Scientific Officer and Executive VP at Stempeutics Research Pvt. Ltd. – A MEMG Group Company in Bangalore was elected as the Vice President- Elect of Asia region of the International Society of cell Therapy to represent India and Asia.
Dr. Anish who has been with Stempeutics Research since 2010, has been leading the R & D for Mesenchymal Stem cell research and therapy. The internationally known stem cell researcher also has been working since 20-25 years towards elucidating the potential of various stem cells and their applications for incurable diseases at Indian and USA organizations. Being nominated a member of the Industry Committee of the International Stem Cell Research and Therapy, this Indian scientist has also delivered more than hundred lectures on various aspects of his research at various National and International conferences.
“Stem cell research and therapy will eventually reshape the healthcare industry and I am honored to be a part of the International Society of cell Therapy to be representing India as well as Asia at an international level. At Stempeutics Research, we have the opportunity to deliver breakthrough solutions which will bring value to our investors, clients and stakeholders.” said Dr. Anish S Majumdar, Chief Scientific Officer and Executive VP, Stempeutics Research.
Stempeutics Research, a Manipal Education and Medical Group enterprise is a leading Stem-Cell Company developing stem cell based medicinal products, with facilities in Bangalore and Manipal (India) as well as in Kuala Lumpur (Malaysia). It was incorporated in Jan 2006. Stempeutics strength lies in developing innovative stem cell products by nurturing cutting edge research and clinical applications through dedicated efforts of its highly qualified team. Currently Stempeutics is developing three products- Stempeutron, Stempeucel and Stempeucare.
Photo caption: Dr Anish Sen Majumdar